MedPath

evaluation of the sedation effect of intranasal ketamine and midazolam to perform gastric aspirates in children: a randomized, pilot study

Phase 4
Conditions
children with suspected tuberculosis who need to perform gastric aspirates for microbiological diagnosis
Registration Number
JPRN-UMIN000010623
Lead Sponsor
no sponsoro for this study
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

known allergy to ketamine or benzodiazepine, ASA classification of III or higher, upper respiratory tract infection with nasal discharge, known liver disease or respiratory distress

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evaluation of the sedative effect of intranasal ketamine and midazolam to perform gastric aspirates in childrn
Secondary Outcome Measures
NameTimeMethod
evaluation of side effects of intranasal ketamine and midazolam to perform gastric aspirates in children: a pilot study
© Copyright 2025. All Rights Reserved by MedPath